Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutation

PURPOSE: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with cytotoxic chemotherapy are highly effective in the treatment of advanced non–small-cell lung cancer (NSCLC) with EGFR mutations. The purpose of this study is to evaluate the efficacy and safety of this com...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Kai, Huang, Hongxiang, Xu, Yongkang, Liu, Yangyang, Lu, Zhihui, Chen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743525/
https://www.ncbi.nlm.nih.gov/pubmed/36503478
http://dx.doi.org/10.1186/s12885-022-10391-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743525/
https://www.ncbi.nlm.nih.gov/pubmed/36503478
http://dx.doi.org/10.1186/s12885-022-10391-z

Ejemplares similares